ArticleMultiple sclerosis and related disorders2020

B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran.

Farinaz Safavi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.